TryVvio Nominated for Prestigious Prix Galien USA Award
Idorsia’s hypertension drug, Tryvio (aprocitentan), has been nominated for the prestigious Prix Galien USA award in the “Best Pharmaceutical...
eClinical Tech News
x4 Pharmaceuticals Gets $60M Equity Financing, Changes Management
X4 Pharmaceuticals secures $60 million in PIPE financing, marking a strategic inflection point for the rare disease company. This...
Rakovina & NanoPalm Announce Joint Venture for AI Oncology Therapies
Rakovina Therapeutics and Nanopalm are joining forces to develop novel oncology therapeutics, starting with KT-3283, a dual PARP-HDAC inhibitor,...
Imagene and Ikena Oncology Merger and $75M Private Placement Complete
Inmagene Biopharmaceuticals and Ikena Oncology have finalized their merger, creating Imagenebio, a clinical-stage biotech focused on immunology and inflammatory...
Agios’ Pyrukynd® (Mitapivat) Approved for Thalassemia in Saudi Arabia
Agios Pharmaceuticals has secured its first regulatory win for Pyrukynd (mitapivat) in thalassemia, with the Saudi Food and Drug...
Bobot Debuts as Public Company: Targeting RAS Pathway Malignancies
BridgeBio Oncology Therapeutics (BBOT) has officially launched on the Nasdaq Global Market under the ticker symbol “BBOT,” following a...
Kamada Gets FDA Nod for Houston Plasma Center
Kamada Ltd. has received FDA approval for its Houston plasma collection center to begin commercial sales of normal source...
CDT Equity Inc.: Conduit to Change Name
Conduit Pharmaceuticals, now rebranded as CDT Equity Inc., is shifting from a traditional pharmaceutical model to a lean, asset-centric...
Clearmind Medicine Gets IRB Approval for Alcohol Use Disorder Trial
Clearmind Medicine has secured Institutional Review Board (IRB) approval from Hadassah Medical Center in Jerusalem for its ongoing Phase...
Cho Plus & BARDA BioMAP: Filovirus Antibody Cell Lines
CHO Plus Secures BARDA Funding to Bolster Biodefense Manufacturing Capabilities CHO Plus, Inc. has been awarded up to $10.4...